Blog
RSS FeedPosted by Michael Wonder on 05 Apr 2023
PHARMAC shares next steps in reviewing rule 8.1b
5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...
Posted by Michael Wonder on 04 Apr 2023
PHARMAC seeking feedback on the COVID-19 anti-viral molnupiravir
4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments. ...
Posted by Michael Wonder on 01 Apr 2023
New Zealand Pharmaceutical Schedule - 1 April 2023
1 April 2023 The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Mar 2023
Clarity around PHARMAC’s priority lists
30 March 2023 - PHARMAC released its first Clarity Report, containing the latest information about medicines, vaccines, and related products ...
Posted by Michael Wonder on 23 Mar 2023
PHARMAC considers funding rituximab for IgG4 related disease
23 March 2023 - PHARMAC has initiated a consultation today on widening funded access to rituximab (branded as Riximyo) for ...
Posted by Michael Wonder on 21 Mar 2023
Lobbying firms earning hundreds of thousands from contracts with Government agencies
20 March 2023 - The government drug buying agency PHARMAC made extensive use of Wellington firm Draper Cormack Group. ...
Posted by Michael Wonder on 20 Mar 2023
Indira Stewart on being called 'likely prejudiced' by PHARMAC
20 March 2023 - PHARMAC has today been “outed” for using a media-avoiding strategy, something many journalists have long suspected. ...
Posted by Michael Wonder on 12 Mar 2023
‘When’s our turn?’ PHARMAC's new funding won't cover breast cancer fighter's $100k bill
13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...
Posted by Michael Wonder on 07 Mar 2023
PHARMAC funds two new treatments for lung cancer
7 March 2023 - PHARMAC has announced the funding of two new medicines - pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for people ...
Posted by Michael Wonder on 07 Mar 2023
PHARMAC announces decision to fund Trikafta
7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic ...
Posted by Michael Wonder on 03 Mar 2023
'Death sentence' for mum with skin cancer without $100k for the drugs she needs
3 March 2023 - Jen Rowlands, 43, faces certain death from terminal cancer without a specific drug that could radically improve ...
Posted by Michael Wonder on 03 Mar 2023
PHARMAC releases final response to review
3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...
Posted by Michael Wonder on 02 Mar 2023
PHARMAC confirms widened access for the funded flu vaccine
2 March 2023 - PHARMAC is widening access to the annual funded flu vaccine to tamariki aged 6 months to 12 ...
Posted by Michael Wonder on 28 Feb 2023
New Zealand Pharmaceutical Schedule - 1 March 2023
1 March 2023 - The March 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Feb 2023
PHARMAC will fund meningococcal B vaccine for babies, teens and young people
28 February 2023 - From Wendesday, PHARMAC will fund meningococcal B vaccine for a number of potentially at-risk groups including ...